Because APOE-ɛ4 non-carriers have more variability than carriers in Alzheimer’s disease subtypes,80 the observed lower contributions from topological proximity to epicentres’ proxies could be driven by a less homogeneous distribution of the imaging biomarkers across non-carriers, rendering the impact of epicentres less salient. This evidence concerns the gene APOE and Alzheimer disease.